| Derek D Ou, MD | |
|
1400 N Interstate 35, Suite C3.314, Austin, TX 78701-1926 | |
| (512) 324-7000 | |
| Not Available |
| Full Name | Derek D Ou |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1400 N Interstate 35, Austin, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053678318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | BP10042998 (Texas) | Primary |
| Entity Name | Travis County Emergency Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962440933 PECOS PAC ID: 0840289468 Enrollment ID: O20040510000492 |
News Archive
Most heroin users in Baltimore, a city heavily affected by the opioid epidemic, recognize that the heroin they buy is now almost always laced with the highly dangerous synthetic opioid fentanyl, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).
ACUO TECHNOLOGIES, developers of high-performance medical image management software, data migration tools and services, is pleased to announce that the United States Patent and Trademark Office has approved a patent application for an "Asset Communication Format within a Computer Network."
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
Breast milk and breastfeeding are recognized to be the ideal choices of nutrition and feeding for infants.
› Verified 1 days ago
| Entity Name | Leading Edge Emergency Physicians, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003165259 PECOS PAC ID: 2466601588 Enrollment ID: O20121005000189 |
News Archive
Most heroin users in Baltimore, a city heavily affected by the opioid epidemic, recognize that the heroin they buy is now almost always laced with the highly dangerous synthetic opioid fentanyl, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).
ACUO TECHNOLOGIES, developers of high-performance medical image management software, data migration tools and services, is pleased to announce that the United States Patent and Trademark Office has approved a patent application for an "Asset Communication Format within a Computer Network."
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
Breast milk and breastfeeding are recognized to be the ideal choices of nutrition and feeding for infants.
› Verified 1 days ago
| Entity Name | Round Table Physicians Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023439114 PECOS PAC ID: 0547682460 Enrollment ID: O20200623002513 |
News Archive
Most heroin users in Baltimore, a city heavily affected by the opioid epidemic, recognize that the heroin they buy is now almost always laced with the highly dangerous synthetic opioid fentanyl, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).
ACUO TECHNOLOGIES, developers of high-performance medical image management software, data migration tools and services, is pleased to announce that the United States Patent and Trademark Office has approved a patent application for an "Asset Communication Format within a Computer Network."
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
Breast milk and breastfeeding are recognized to be the ideal choices of nutrition and feeding for infants.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derek D Ou, MD 722 Lakeshore Dr, Sugar Land, TX 77478-4715 Ph: (832) 863-1388 | Derek D Ou, MD 1400 N Interstate 35, Suite C3.314, Austin, TX 78701-1926 Ph: (512) 324-7000 |
News Archive
Most heroin users in Baltimore, a city heavily affected by the opioid epidemic, recognize that the heroin they buy is now almost always laced with the highly dangerous synthetic opioid fentanyl, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).
ACUO TECHNOLOGIES, developers of high-performance medical image management software, data migration tools and services, is pleased to announce that the United States Patent and Trademark Office has approved a patent application for an "Asset Communication Format within a Computer Network."
The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.
Breast milk and breastfeeding are recognized to be the ideal choices of nutrition and feeding for infants.
› Verified 1 days ago
Dr. Suprina Dorai, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 8721 Menchaca Rd, Austin, TX 78748 Phone: 512-280-6959 | |
Nicole Maree Hotchkiss, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6300 La Calma Dr Ste 200, Austin, TX 78752 Phone: 512-452-8533 | |
Dr. Gurpreet Basraon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 12201 Renfert Way Ste 105, Austin, TX 78758 Phone: 877-800-5722 | |
Kimberly Snyder, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 12221 N. Mopac Expressway, Austin, TX 78758 Phone: 512-901-1000 | |
Rex E. Medford, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Ronald S. Kim, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Dr. Jose Veloso, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6300 La Calma Dr, Suite 200 C/o Esp, Austin, TX 78752 Phone: 815-382-4520 |